Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

291.16 -5.81 (-1.96%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
50 51 Next >
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
The second wave of the weight loss drug stock boom is underway and investors should heed the signs the market is serving. 
Via InvestorPlace
Trade Desk To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Wall Street Stares At Weaker Open On Rate Anxiety, Hopes For Better Earnings: Analyst Pencils Key S&P 500 Support Level
Trading in U.S. index futures suggests stocks may be off to a lackluster start again on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Market Whales and Their Recent Bets on AMGN Options
Via Benzinga
How Is The Market Feeling About Amgen?
Via Benzinga
Check Out What Whales Are Doing With AMGN
Via Benzinga
Sector Superstars: 3 Stocks Generating the Most Buzz on Wall Street
Discover the reasons behind three stocks attracting investor attention as they stand on the precipice of future growth. 
Via InvestorPlace
Dow Jones Industrial Average Pushes Higher On Wednesday Despite Tepid Risk Appetite
Via Talk Markets
Topics Stocks
Exposures US Equities
3 Tried and True Dividend Stocks to Buy for Your Portfolio
These dividend stocks to buy represent time-tested companies with significant growth potential. Dive in now to strengthen your portfolio. 
Via InvestorPlace
The Option Market Shows The Way Through This Low-Volume, Fed-Driven Melt-Up
The S&P 500 ended today’s session a little more than 1% higher than where it started. At the same time, trading volume in equities has been very light. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Via Benzinga
Market Briefing For Monday, May 6, 2024
So prospects for a Fed rate-cut are enhanced by 'mediocre or bad' news on Jobs and Manufacturing fronts. Not a lot; but helps as at least it's not particularly more inflationary; and not a bad... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update
As the demand for obesity drugs continues to surge, biopharma companies are eagerly seizing the opportunity to capitalize on the trend. 
Via Benzinga
Dow Jones Industrial Average Gains 450 Points As Investors Up Rate Cut Bets After Softer NFP
The Dow Jones Industrial Average gained nearly 1.2% on Friday after a broad miss from US Nonfarm Payrolls) and other key labor data revealed a steep weakening in the US domestic economy, sparking... 
Via Talk Markets
Topics Economy Stocks
Exposures Economy US Equities
Why Amgen Stock Zoomed Nearly 12% Higher Today
The company delivered solid quarterly results, but its discussion of an investigational drug is what really gave its shares a pop. 
Via The Motley Fool
Stocks Rally As Jobs Report Rekindles Rate Cut Hopes, Apple Rockets, Bitcoin Soars Above $61,000: What's Driving Markets Friday?
A weaker-than-expected jobs report sparked a widespread market rally in the last session of the week, as traders increased expectations on potential interest rate cuts later this year. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review
The Nasdaq regained its 50-day line Friday. The other indexes hit resistance. 
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value
Amgen earnings beat estimates, and MariTide's promising Phase 2 results suggest significant differentiation from competitors. 
Via Benzinga
Topics Earnings
Exposures Financial
Why Is WideOpenWest (WOW) Stock Up 30% Today?
WideOpenWest stock is up on Friday after the technology company received a $4.80 per share in cash takeover offer for WOW shares. 
Via InvestorPlace
Wage Growth Slows – Stock Market Celebrates, Five Real Reasons Apple Is Running Up
To gain an edge, this is what you need to know today. 
Via Benzinga
AMGN Stock Alert: Is Amgen the Next Hot Weight-Loss Drug Company?
Amgen (AMGN) stock is soaring after the company's CEO said he was "very encouraged" by interim data for Amgen's new weight-loss drug. 
Via InvestorPlace
Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday
Via Benzinga
Wall Street Looks To Feed Off Apple's Post-Earnings Power But Key Jobs Data May Upset The Cart: Analyst Says 'A Lot Of These Clouds Will Lift' If This Happens
Stocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although a tinge of nervousness is evident ahead of the all-important non-farm payrolls report. 
Via Benzinga
Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Amgen Stock Adds Good Weight After CEO's Update On Experimental Drug Rivaling Ozempic, Nixing Oral Weight-Loss Candidate
MariTide, formerly AMG 133, is an injectable form of drug targeting two gut hormones — gastric inhibitory polypeptide receptor, or GIP, and glucagon-like peptide 1, or GLP-1. 
Via Benzinga
Apple, Coinbase, Block, Amgen, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Thursday saw major U.S. indices closing on a positive note, with the Dow Jones Industrial Average climbing 0.85% to reach 38,225.66 
Via Benzinga
Topics Stocks
Exposures US Equities
AMGN Stock Earnings: Amgen Beats EPS, Beats Revenue for Q1 2024
AMGN stock results show that Amgen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment
Amgen reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.87 by 2.33%. The company said EPS decreased by 1% due to higher operating and interest expenses... 
Via Benzinga
Amgen Beats First-Quarter Expectations, But Shares Slide As Investors Watch Obesity Space
The company confirmed it's still running a midstage study of its obesity drug, MariTide. 
Via Investor's Business Daily
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
50 51 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.